G1 Therapeutics to Participate in the 21st Annual Needham Virtual Healthcare Conference

Rhea-AI Summary

G1 Therapeutics, a commercial-stage oncology company, announced participation in the 21st Annual Needham Virtual Healthcare Conference. CEO Jack Bailey and CMO Raj Malik will engage in a fireside chat on April 13, 2022, at 11:00 AM EDT. The event will be accessible via live webcast on their website. G1 Therapeutics focuses on developing next-generation cancer therapies, including COSELA™ (trilaciclib), with a robust clinical pipeline aimed at treating various solid tumors. For more information, visit www.g1therapeutics.com.

RESEARCH TRIANGLE PARK, N.C., April 06, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that Jack Bailey and Raj Malik, M.D., G1’s Chief Executive Officer and Chief Medical Officer, respectively, will participate in a fireside chat during the 21st Annual Needham Virtual Healthcare Conference. The fireside chat will take place on Wednesday April 13, 2022, at 11:00 AM EDT. This meeting is being held virtually, and a live webcast will be accessible on the Events & Presentations page of http://www.g1therapeutics.com.

About G1 Therapeutics
G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of next generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product, COSELA™ (trilaciclib). G1 has a deep clinical pipeline and is executing a tumor-agnostic development plan evaluating COSELA in a variety of solid tumors, including colorectal, breast, lung, and bladder cancers. G1 Therapeutics is based in Research Triangle Park, N.C. For additional information, please visit www.g1therapeutics.com and follow us on Twitter @G1Therapeutics.

Contacts:
Will Roberts
Vice President, Investor Relations & Corporate Communications
919-907-1944
wroberts@g1therapeutics.com

FAQ

When is G1 Therapeutics participating in the 21st Annual Needham Virtual Healthcare Conference?

G1 Therapeutics will participate in the conference on April 13, 2022, at 11:00 AM EDT.

Who from G1 Therapeutics will speak at the Needham Conference?

CEO Jack Bailey and CMO Raj Malik will represent G1 Therapeutics during the conference.

How can I watch the G1 Therapeutics fireside chat live?

The fireside chat can be viewed via live webcast on G1 Therapeutics' Events & Presentations page.

What is the focus of G1 Therapeutics?

G1 Therapeutics is focused on developing therapies to improve the lives of cancer patients, with COSELA™ as its first product.

What types of cancer does G1 Therapeutics' COSELA target?

COSELA is being evaluated in various solid tumors, including colorectal, breast, lung, and bladder cancers.